Sandra Duquesne

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun et al. · Nature Medicine · 2018 · 283 citations · Full text

Cell Therapy, Flt3-itd-mutant Leukemia Cells, Immunology +7

Oncogenic JAK2 ^V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Alessandro Prestipino, Alica Joana Emhardt, Konrad Aumann et al. · Science Translational Medicine · 2018 · 218 citations · Full text

Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation

Shaima’a Hamarsheh, Benedikt S. Saller, Susanne Unger et al. · Nature Communications · 2020 · 144 citations · Full text

Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset

Jan Hülsdünker, Katja Ottmüller, Hannes Neeff et al. · Blood · 2018 · 142 citations · Full text

Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans

Franziska Maria Uhl, Sophia Chen, David O’Sullivan et al. · Science Translational Medicine · 2020 · 124 citations · Full text

Cell Therapy, Mixed-phenotype Acute Leukemia, T-regulatory Cell +23